Professional Summary

Professional Overview

Kevin Lloyd is an experienced pharmaceutical executive with a strong track record in program leadership, alliance management, and clinical operations. He currently serves as the Vice President of Program Leadership at Morphic Therapeutic, where he oversees the strategic planning and execution of the company's drug development programs.

Experience Summary

Current Role

As the Vice President of Program Leadership at Morphic Therapeutic, Kevin is responsible for leading the strategic planning and implementation of the company's key drug development programs. He collaborates closely with the R&D, clinical, and business development teams to ensure efficient and effective program management, and works to align internal and external stakeholders to achieve Morphic's strategic objectives.

Career Progression

Kevin's pharmaceutical career spans over 25 years, during which he has held various leadership roles in program management, alliance management, and clinical operations. Prior to joining Morphic, he served as the Vice President of Program & Alliance Management at Leap Therapeutics and Tetraphase Pharmaceuticals, where he was instrumental in advancing the companies' drug development pipelines and forging strategic collaborations.

Earlier in his career, Kevin held positions at Molecular Insight Pharmaceuticals, ZIOPHARM Oncology, Millennium Pharmaceuticals, and ImmunoGen, where he gained extensive experience in clinical operations, project management, and business development. His diverse background and deep industry knowledge have enabled him to drive successful outcomes at each stage of his career.

Academic Background

Kevin holds a Bachelor of Science degree in Biology from Tufts University, where he graduated with honors.

Areas of Expertise

• Program leadership and strategic planning

• Alliance management and cross-functional collaboration

• Clinical operations and project management

• Pharmaceutical drug development and commercialization

• Regulatory compliance and quality assurance

Professional Impact

Throughout his career, Kevin has demonstrated a strong commitment to advancing the development of innovative therapies. He has led the successful execution of numerous drug development programs, resulting in the advancement of multiple drug candidates through clinical trials and regulatory approval processes. Kevin's collaborative approach and strategic leadership have earned him a reputation as a trusted partner within the pharmaceutical industry.

Conclusion

With his extensive experience, industry knowledge, and proven track record of success, Kevin Lloyd is well-positioned to continue driving meaningful progress in the pharmaceutical industry. As the Vice President of Program Leadership at Morphic Therapeutic, he is committed to leveraging his expertise to advance the company's pipeline and deliver transformative therapies to patients.